WHO ICTRP trial
Anticoagulant medication for the treatment of patients with teared brain…
EUCTR2015-003200-23-DE · EU Clinical Trials Register · Not Recruiting
Key facts
| Trial ID | EUCTR2015-003200-23-DE |
|---|---|
| Public title | Anticoagulant medication for the treatment of patients with teared brain supplying vessels |
| Scientific title | Biomarkers and antithrombotic treatment in cervical artery dissection (TREAT-CAD) - TREAT-CAD |
| Primary sponsor | University Hospital Basel; Neurology |
| Registry | EU Clinical Trials Register |
| Recruitment status | Not Recruiting |
| Study type | Interventional clinical trial of medicinal product |
| Phase | Human pharmacology (Phase I): no Therapeutic exploratory (Phase II): no Therapeutic confirmatory - (Phase III): no Therapeutic use (Phase IV): yes |
| Countries | Denmark;Germany;Switzerland |
| Conditions | cervical artery dissection;Therapeutic area: Diseases [C] - Cardiovascular Diseases [C14] |
| Interventions | Trade Name: Aspirin protect 300 Pharmaceutical Form: Gastro-resistant tablet INN or Proposed INN: Acetylsalicylsäure Other descriptive name: ASPIRIN PH. EUR Concentration unit: mg milligram(s) Concentration type: equal Concentration number… |
| Registration date | Jan 27, 2016 |
| Target size | 194 |
| Secondary IDs | 2013DR3084;NCT02046460 |
| Registry page | clinicaltrialsregister.eu |
At a glance
- Yes Results available
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About WHO ICTRP trial registrations
The WHO ICTRP combines trial registrations from primary registries worldwide into a single searchable index. Contact and ethics-committee details are not shown here.
Source: World Health Organization (WHO), International Clinical Trials Registry Platform (ICTRP) · Source date: